MRD Detection In MM
C. Ola Landgren, M.D. Chief of the Myeloma Service in the Division of Hematologic Oncology at Memorial Sloan Kettering Cancer Center Discusses MRD Detection In MM at Lymphoma & Myeloma on October 18, 2018.
Multiple Myeloma
Sarclisa Phase 2 GMMG-CONCEPT Carfilzomib, Lenalidomide, and Dexamethasone
25 Views
Bispecific Antibodies: Revolution in Oncology
47 Views
A New Refractory Multiple Myeloma Treatment: SUCCESSOR-2 trial
104 Views
Multiple Myeloma Cancer Disparities, A Global Perspective on Drug Toxicity Trends
72 Views
Global Disparities in Multiple Myeloma: Insights from FAERS Analysis
642 Views
Teclistamab Long-term Response RR Multiple Myeloma
28 Views
Multiple Myeloma the Phase 3 SUCCESSOR-2 Trial MeziKd Verses Kd
195 Views
MonumenTAL-1 Results a Pivotal Phase 2 Trial of Talquetamab in RRMM
144 Views
Standard of Care the Safety and Efficacy of Cilta-cel for RRMM Patients
46 Views
Idecabtagene Vicleucel Shows Effectiveness and Safety in High-Risk Multiple Myeloma Patients Krina Patel MD
63 Views
REGN5458: A Trial for Relapsed/Refractory Multiple Myeloma a BCMAxCD3 Bispecific Antibody Naresh Bumma MD
123 Views
![2023 ASH Multiple Myeloma Updates [Slides] - Lisa Lee, MD MOASC](https://oncologytubecom.cdn.ypt.me/videos/video_230214195313_v07fa/video_230214195313_v07fa_thumbsV2_jpg.webp?cache=1684358235_1691419093 "2023 ASH Multiple Myeloma Updates [Slides] - Lisa Lee, MD MOASC")
2023 ASH Multiple Myeloma Updates [Slides] - Lisa Lee, MD MOASC
51 Views